Search Results - "Iliceto, G."

Refine Results
  1. 1

    Gender effect on non-motor symptoms in Parkinson's disease: A men more at risk? by Nicoletti, A, Vasta, R, Mostile, G, Nicoletti, G, Arabia, G, Iliceto, G, Lamberti, P, Marconi, R, Morgante, L, Barone, P, Quattrone, A, Zappia, M

    Published in Parkinsonism & related disorders (01-02-2017)
    “…Abstract Introduction Several gender differences have been reported in Parkinson's Disease (PD). We evaluated the burden of non-motor symptoms (NMS) in PD and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy by Bovenzi, Roberta, Liguori, Claudio, Canesi, Margherita, D’Amelio, Marco, De Pandis, Maria Francesca, Marini, Carmine, Monge, Alessandra, Padovani, Alessandro, Tessitore, Alessandro, Stefani, Alessandro, Zappia, Mario

    Published in Neurological sciences (01-02-2024)
    “…Introduction Safinamide is a recent antiparkinsonian drug that modulates both dopaminergic and glutamatergic systems with positive effects on motor and…”
    Get full text
    Journal Article
  4. 4

    Action tremor in Parkinson's disease: frequency and relationship to motor and non-motor signs by Gigante, A. F., Bruno, G., Iliceto, G., Guido, M., Liuzzi, D., Mancino, P. V., De Caro, M. F., Livrea, P., Defazio, G.

    Published in European journal of neurology (01-02-2015)
    “…Background and purpose Action tremor may occur in patients with Parkinson's disease and cause misdiagnosis with other movement disorders such as essential…”
    Get full text
    Journal Article
  5. 5

    Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings by Gigante, A. F., Defazio, G., Niccoli Asabella, A., Superbo, M., Ferrari, C., Liuzzi, D., Iliceto, G., Livrea, P., Rubini, G.

    Published in Acta neurologica Scandinavica (01-10-2016)
    “…Objective To assess whether cigarette smoking interferes with dopaminergic transmission in current‐ and never‐smoking patients with Parkinson's disease…”
    Get full text
    Journal Article
  6. 6

    Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? by Zoccolella, S, Lamberti, S V, Iliceto, G, Santamato, A, Lamberti, P, Logroscino, G

    Published in Current medicinal chemistry (01-09-2010)
    “…Hyperhomocysteinemia has been associated with cognitive dysfunction and dementia. The incidence of dementia in Parkinson's Disease (PD) patients is higher than…”
    Get more information
    Journal Article
  7. 7

    Hyperhomocysteinemia in l-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration by Lamberti, P., Zoccolella, S., Armenise, E., Lamberti, S. V., Fraddosio, A., de Mari, M., Iliceto, G., Livrea, P.

    Published in European journal of neurology (01-05-2005)
    “…Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment and dementia. l‐dopa treatment may represent an acquired cause of…”
    Get full text
    Journal Article
  8. 8

    Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications by Zoccolella, S., Lamberti, P., Armenise, E., Mari, M. de, Lamberti, S.V., Mastronardi, R., Fraddosio, A., Iliceto, G., Livrea, P.

    Published in Parkinsonism & related disorders (01-03-2005)
    “…Elevated plasma homocysteine (Hcy) concentrations have been reported in l-dopa treated Parkinson's disease (PD) patients, suggesting that l-dopa treatment is…”
    Get full text
    Journal Article
  9. 9

    Natural history and clinical features of progressive supranuclear palsy: a clinical study by Diroma, C, Dell'Aquila, C, Fraddosio, A, Lamberti, S, Mastronardi, R, Russo, I, De Mari, M, Iliceto, G

    Published in Neurological sciences (01-10-2003)
    “…Progressive supranuclear palsy (PSP or Steele-Richardson-Olszewski syndrome) is one of the most-common types of atypical parkinsonism. To characterize the…”
    Get full text
    Journal Article
  10. 10

    ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism by Zoccolella, S, Palagano, G, Fraddosio, A, Russo, I, Ferrannini, E, Serlenga, L, Maggio, F, Lamberti, S, Iliceto, G

    Published in Neurological sciences (01-09-2002)
    “…According to El Escorial criteria, amyotrophic lateral sclerosis (ALS), combined with other neurologic disorders, such as dementia and parkinsonism, is defined…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy by Federico, F, Simone, I L, Lucivero, V, De Mari, M, Giannini, P, Iliceto, G, Mezzapesa, D M, Lamberti, P

    “…OBJECTIVES: Proton magnetic resonance spectroscopy (1H-MRS) localised to the lentiform nucleus, was carried out in eight patients with idiopathic Parkinson's…”
    Get full text
    Journal Article
  13. 13

    Post-vaccinic opsoclonus–myoclonus syndrome: a case report by Lapenna, F, Lochi, L, de Mari, M, Iliceto, G, Lamberti, P

    Published in Parkinsonism & related disorders (01-10-2000)
    “…The opsoclonus–myoclonus syndrome is a pathological condition characterized mainly by involuntary myoclonic movements involving ocular, trunk and limb muscles…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Efficacy and tolerability of dopamine agonists in a parkinsonian population by Zenzola, A, Diroma, C, Fraddosio, A, Lamberti, S, Moramarco, A, Palagano, G, Iliceto, G

    Published in Neurological sciences (01-02-2001)
    “…A clinical retrospective study was carried out in a population of 366 Parkinson's disease (PD) outpatients, to analyse the efficacy and tolerability of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Diaphragmatic flutter, the moving umbilicus syndrome, and "belly dancer's" dyskinesia by Iliceto, G, Thompson, P D, Day, B L, Rothwell, J C, Lees, A J, Marsden, C D

    Published in Movement disorders (1990)
    “…Five patients presenting with focal abnormal involuntary movements of the abdominal wall are described. One was shown to have diaphragmatic flutter, which may…”
    Get more information
    Journal Article
  18. 18

    Subclinical Visual Involvement in Multiple Sclerosis: A Study by MRI, VEPs, Frequency-Doubling Perimetry, Standard Perimetry, and Contrast Sensitivity by Sisto, Dario, Trojano, Maria, Vetrugno, Michele, Trabucco, Tiziana, Iliceto, Giovanni, Sborgia, Carlo

    “…To evaluate the effectiveness of visual evoked potentials (VEPs), frequency-doubling perimetry (FDP), standard achromatic perimetry (SAP), contrast sensitivity…”
    Get full text
    Journal Article
  19. 19

    Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients by Lamberti, Paolo, Zoccolella, Stefano, Iliceto, Giovanni, Armenise, Elio, Fraddosio, Angela, De Mari, Michele, Livrea, Paolo

    Published in Movement disorders (01-01-2005)
    “…Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment, and dementia. Elevated plasma concentrations of Hcy have been found recently…”
    Get full text
    Journal Article
  20. 20

    Topographic EEG mapping of 3/s spike-and-wave complexes during absence seizures by Ferri, R, Iliceto, G, Carlucci, V

    Published in Italian journal of neurological sciences (01-11-1995)
    “…Topographic color mapping has recently been introduced for the study of ictal EEG manifestations of absences. We recorded 2-4 3/s spike-and-wave (sw) bursts in…”
    Get full text
    Journal Article